BlackRock is smarter, and they have shares of Peregrine. "Most" of the other shares they held could very likely be the middleman holding those shares as they would be allowed to use the equivalent on the flip side....holding a lid on PPHM. Now this gets interesting...because they sold leading up to Sept 2012 and immediately jumped back into Peregrine PPHM.
Why jump back in.... bigger than before? ...well now this gives them the opportunity to short that flipside again...
Could have some agreement been made....because the real players don't want to be revealed too soon and must wait for the right time...
We all agree this IS NOT how a stock behaves...and SEC can certainly agree to some terms for some party to accumulate and in time... that scenario must be made public.
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!